Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Hibiscus anthocyanins help protect the liver and improve antioxidants in diabetic rats.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

The method effectively measures drug impact on DHT levels in prostate treatments.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Rutin may protect against stomach damage caused by sodium valproate.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Saw palmetto extract is effective and safe for treating lower urinary tract symptoms, working as well as certain medications, and works even better in severe cases.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Both treatments for alopecia areata showed similar modest effectiveness.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New compounds may help treat heart disease by activating specific potassium channels.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.